Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 271 - 285 of 530 items.
Unauthorized products may pose serious health risks (September 16, 2020: Part 2)
AlertPublic advisory | 2020-09-16
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
AlertHealth professional risk communication | 2020-09-15
ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver Injury
AlertHealth professional risk communication | 2020-09-14
Hand Sanitizers and Children's Safety: What you need to know
AlertPublic advisory | 2020-09-04
Prescription Cough and Cold Products Containing Opioids and the Risk of Opioid Use Disorder in Children and Adolescents (< 18 years of age)
AlertHealth professional risk communication | 2020-08-24
Accidental ingestion of edible cannabis products causing serious harm to children
AlertPublic advisory | 2020-08-13
Non-prescription pain relief products containing codeine are not recommended for use in people under 18 years of age
AlertPublic advisory | 2020-07-31
Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
AlertPublic advisory | 2020-07-28
Status of ranitidine drugs in Canada
AlertPublic advisory | 2020-07-23
Methadone Treatment of Opioid Dependence and Potential Risk of Lack of Effect when Switching between Different Products
AlertHealth professional risk communication | 2020-07-17
Three lots of antidiuretic DDAVP Spray recalled because of potential overdose risk
AlertPublic advisory | 2020-07-16
Health Canada Advises Canadians to Stop Using and Selling Two Baby's Journey Infant Napper Products
AlertPublic advisory | 2020-07-16
Certain vials of fertility drug Cetrotide recalled because of potential contamination
AlertPublic advisory | 2020-07-04
Information Update - Use of the drug Picato may increase the risk of skin cancer
AlertInformation update | 2020-07-02
NARDIL (phenelzine sulfate) Shortage
AlertHealth professional risk communication | 2020-06-24